Insider Shareholders with Direct Ownership of Allovir, Inc. (ALVR)
This section provides a comprehensive overview of the insiders with direct ownership of Allovir, Inc. (ALVR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Allovir, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Elevate Bio, Llc
Director |
3,253,796 | 0 | 16,674,766 $166 Million | 1 |
Jul 28, 2022
Added 16.33%
|
Gilead Sciences Inc
> 10% Shareholder |
2,930,870 | 0 | 16,635,286 $166 Million | 1 |
Jun 27, 2023
Added 14.98%
|
70,000 | 127,042 | 2,409,928 $24 Million | 11 |
Jun 06, 2024
Added 1.43%
|
|
217,000 | 157,004 | 2,143,662 $21.3 Million | 9 |
Jun 06, 2024
Added 1.61%
|
|
Diana Brainard
Chief Executive Officer |
995,625 | 288,268 | 723,363 $7.2 Million | 39 |
Nov 19, 2024
Reduced 1.19%
|
Agustin Melian
Chief Medical Officer |
43,750 | 121,586 | 453,529 $4.51 Million | 9 |
Oct 04, 2021
Reduced 0.07%
|
Jeroen B Van Beek
Chief Commercial Officer |
87,256 | 278,170 | 333,726 $3.32 Million | 37 |
Nov 16, 2022
Reduced 4.6%
|
Cintia Piccina
Chief Commercial Officer |
147,000 | 0 | 147,000 $1.46 Million | 1 |
Jul 03, 2023
Added 50.0%
|
Ercem Atillasoy
Officer |
65,256 | 12,384 | 131,372 $1.31 Million | 11 |
Oct 20, 2022
Reduced 1.15%
|
Ann M. Leen
Chief Scientific Officer |
124,006 | 60,394 | 124,006 $1.23 Million | 6 |
Feb 02, 2023
Added 26.08%
|
80,000 | 0 | 110,197 $1.1 Million | 4 |
Jun 06, 2024
Added 24.11%
|
|
70,000 | 0 | 100,197 $996,960 | 2 |
Jun 06, 2024
Added 25.89%
|
|
70,000 | 0 | 100,197 $996,960 | 2 |
Jun 06, 2024
Added 25.89%
|
|
70,000 | 0 | 70,000 $696,500 | 2 |
Jun 06, 2024
Added 33.33%
|
|
70,000 | 0 | 70,000 $696,500 | 2 |
Jun 06, 2024
Added 33.33%
|
|
394,538 | 106,099 | 49,432 $491,848 | 42 |
Jan 23, 2025
Reduced 0.03%
|
|
Edward Miller
General Counsel |
167,756 | 225,455 | 6,623 $65,898 | 32 |
Jan 23, 2025
Reduced 0.08%
|
Brett R Hagen
Chief Accounting Officer |
126,692 | 115,440 | 2,928 $29,133 | 51 |
Jan 23, 2025
Reduced 0.14%
|